Lassa fever historical perspective

Jump to navigation Jump to search

Lassa fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Lassa fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lassa fever historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lassa fever historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lassa fever historical perspective

CDC on Lassa fever historical perspective

Lassa fever historical perspective in the news

Blogs on Lassa fever historical perspective

Directions to Hospitals Treating Lassa fever

Risk calculators and risk factors for Lassa fever historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Synonyms and keywords: Lassa hemorrhagic fever; LHF

Overview

The first case of documented Lassa fever was reported in 1969 following the death of 2 nurses in Lassa, Nigeria.[1]Prior to that, similar cases in West Africa were reported and thought to be caused by Lassa fever given the clinical and epidemiological resemblance of the presentation to Lassa fever.

Historical Perspective

  • In 1955-1956, epidemics with clinical and epidemiological resemblance to Lassa fever were reported in Eastern Province and Sierra Leone.
  • The first case of documented Lassa fever was reported in 1969 following the death of 2 nurses in Lassa, Nigeria.[1] Prior to that, similar cases in West Africa were reported and thought to be caused by Lassa fever given the clinical and epidemiological resemblance of the presentation to Lassa fever.
  • Administration of ribavirin for the treatment of Lassa fever was first introduced by Joe McCormick in 1979.
  • Lassa fever is uncommon outside West Africa. Only 6 patients with Lassa fever have historically been hospitalized in USA (all 6 patients had recently traveled to West Africa). The most recent case of Lassa fever in USA was reported in May 2015.
Year of import Occupation From To Clinical outcome
1971 Nurse Sierra Leone United Kingdom Survived
1971 Physician Sierra Leone United Kingdom Survived
1972 Nurse Sierra Leone United Kingdom Survived
1974 Physician Nigeria Germany Survived
1975 Physician Nigeria United Kingdom Died
1976 Engineer Nigeria United Kingdom Survived
1980 Aid worker Upen Volta Netherlands Survived
1981 Teacher Nigeria United Kingdom Survived
1982 Diplomat Nigeria United Kingdom Survived
1984 Geologist Sierra Leone United Kingdom Survived
1985 Nurse Sierra Leone United Kingdom Survived
1987 Engineer Sierra Leone/Liberia Israel Survived
1987 Engineer Sierra Leone Japan Survived
1989 Agricultural specialist Nigeria Canada Survived
2000 Student Cotê d'Ivoire/Burkina Faso/Ghana Germany Died
2000 Peace Keeper CSierra Leone United Kingdom Died
2000 Unknown Nigeria Germany Died
2000 Physician Sierra Leone Netherlands Died
2003 Peace Keeper Sierra Leone United Kingdom Survived
2006 - Sierra Leone Germany Survived

Data from the Center of Disease Control and Prevention, as of May 2015

A physician examining a patient with Lassa fever patient in West Africa in 1977.
Image retrieved from the Centers for Disease Control and Prevention (CDC) - Lassa Fever History[2]

References

  1. Monath TP (1975). "Lassa fever: review of epidemiology and epizootiology". Bull World Health Organ. 52 (4–6): 577–92. PMC 2366662. PMID 782738.
  2. "Public Health Image Library (PHIL), Centers for Disease Control and Prevention- Lassa fever history".